Pegloticase

Category: Gout



Pegloticase Overview

Pegloticase (trade name Krystexxa) is a medication for the treatment of severe, treatment-refractory, chronic gout. It is a third line treatment in those in whom other treatments are not tolerated.[1] The drug is administered by infusion intravenously. It was developed by Savient Pharmaceuticals.[2][3] It was approved in the United States in 2010, after two clinical trials found it lowered uric acid levels and reduced deposits of uric acid cryst...

Read more Pegloticase Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegloticase

Recent Pegloticase Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pegloticase
  • Injection: 8mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pegloticase or a similar ingredient: (1 result)

Related Pegloticase Topics:

Pegloticase
sir can you send me full article of same to below mentioned email...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA